CXCR4-targeted near-infrared imaging allows detection of orthotopic and metastatic human osteosarcoma in a mouse model

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Guan, Guofeng ^a,b   Lu, Yao ^a   Zhu, Xiaodong ^b   Liu, Lijuan ^b   Chen, Jie ^a   Ma, Qiong ^a   Zhang, Yinglong ^a   Wen, Yanhua ^a   Yang, Lianjia ^a   Liu, Tao ^a   Wang, Wei ^c   Ran, Henry ^c   Qiu, Xiuchun ^a   Ke, Shi ^c,d   Zhou, Yong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b BINZHOU MEDICAL UNIVERSITY   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4;

ANIMAL; BAGG ALBINO MOUSE; BONE TUMOR; DISEASE MODEL; FEMALE; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NUDE MOUSE; OSTEOSARCOMA; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; SECONDARY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, FLUORESCENCE; OPTICAL IMAGING; OSTEOSARCOMA; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, CXCR4; TRANSPLANTATION, HETEROLOGOUS; X-RAY MICROTOMOGRAPHY;

EID: 84944270889     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15244     Document Type: Article

References (31)

1. Ottaviani G., Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res. 2152, 3-13 (2009).
2. Carrle D., Bielack S. S. Current strategies of chemotherapy in osteosarcoma. Int Orthop. 30, 445-451 (2006), doi: 10.1007/s00264-006-0192-x.
3. Hughes DPM. Strategies for the targeted delivery of therapeutics for osteosarcoma. Expert Opin Drug Deliv. 6, 1311-1321 (2009).
4. Etzioni R. et al. The case for early detection. Nat Rev Cancer. 3, 243-252 (2003).
5. Kundu Z. S. Classification, imaging, biopsy and staging of osteosarcoma. Indian J Orthop. 48, 238-246 (2014).
6. Weissleder R. Molecular Imaging in Cancer. Science. 312, p 1168-1171 (2006).
7. Oda Y. et al. CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis. Mod Pathol. 19, 738-745 (2006).
8. Laverdiere C. et al. Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma. Clin Cancer Res. 11, 2561-2567 (2005).
9. Nayak T. R. et al. Multimodality imaging of CXCR4 in cancer: current status towards clinical translation. Curr Mol Med. 13, 1538-1548 (2013).
10. Weiss I. D. et al. Positron emission tomography imaging of tumors expressing the human chemokine receptor CXCR4 in mice with the use of 64Cu-AMD3100. Mol Imaging Biol. 14, 106-114 (2012).
11. Jacobson O. et al. Improvement of CXCR4 tracer specificity for PET imaging. J Control Release. 157, 216-223 (2012).
12. Nimmagadda S. et al. Molecular imaging of CXCR4 receptor expression in human cancer xenografts with [64Cu]AMD3100 positron emission tomography. Cancer Res. 70, 3935-3944 (2010).
13. Kosaka N. et al. Clinical implications of near-infrared fluorescence imaging in cancer. Future Oncol. 5, 1501-1511 (2009).
14. Hilderbrand S. A.,Weissleder R. Near-infrared fluorescence: application to in vivo molecular imaging. Curr Opin Chem Biol. 14, 71-79 (2010).
15. Ntziachristos V. et al. Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol. 23, 313-320 (2005).
16. Troyan S. L. et al. The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol. 16, 2943-2952 (2009).
17. Hirsch J. C. et al. Near-infrared spectroscopy: what we know and what we need to know-a systematic review of the congenital heart disease literature. J Thorac Cardiovasc Surg. 137, 154-159 151e-159e (2009).
18. Meincke M. et al. Near-infrared molecular imaging of tumors via chemokine receptors CXCR4 and CXCR7. Clin Exp Metastasis. 28, 713-720 (2011).
19. Chen X. et al. Establishment and characterization of human osteosarcoma cell lines with different pulmonary metastatic potentials. Cytotechnology. 61, 37-44 (2009).
20. Weiss I. D., Jacobson O. Molecular imaging of chemokine receptor CXCR4. Theranostics. 3, 76-84 (2013).
21. Adams K. E. et al. Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. J Biomed Opt. 12, p 024017 (2007).
22. Demos S. G. et al. Near-infrared autofluorescence imaging for detection of cancer. J Biomed Opt. 9, 587-592 (2004).
23. Teicher B. A., Fricker S. P. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res. 16, 2927-2931 (2010).
24. Ngo H. T. et al. SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia. Blood. 112, 150-158 (2008).
25. Yang Y. C. et al. CXCR4 expression is associated with pelvic lymph node metastasis in cervical adenocarcinoma. Int J Gynecol Cancer. 17, 676-686 (2007).
26. Mongan J. P. et al. Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines. Clin Colorectal Cancer. 8, 100-105 (2009).
27. Massoud T. F., Gambhir S. S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 17, 545-580 (2003).
28. Wang W. et al. An imageable retinoid acid derivative to detect human cancer xenografts and study therapeutic dosing to reduce its toxicity. Contrast Media Mol Imaging. 6, 200-208 (2011).
29. Ward W. G. et al. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases. J Clin Oncol. 12, 1849-1858 (1994).
30. Luu H. H. et al. An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin Exp Metastasis. 22, 319-329 (2005).
31. Lee B. T. et al. The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in perforator flap breast reconstruction. Plast Reconstr Surg. 126, 1472-1481 (2010).